Cognis has acquired an interest in InterMed Discovery GmbH and, according to a press release, signed a cooperation agreement to ensure access to one of the world’s largest natural product data bases and exclusive access to selected potential active ingredients for specific applications in functional foods, dietary supplements, and personal and home care products. This cooperation with InterMed Discovery allows Cognis to strengthen its portfolio of natural source products and compounds and to create the basis for further success in the innovation-driven growth markets of wellness and sustainability.
InterMed Discovery GmbH researches and develops active ingredients based on natural products. The company owns one of the world’s largest proprietary collections of biologically-active natural substances and extracts. Using its technology platform, InterMed Discovery can correlate chemical structures with biological activity on a large scale and identify novel active ingredients with defined applications. Together with InterMed Discovery Cognis will utilize this data base and technology to select, develop and market suitable active substances exclusively.
The cooperation with Cognis allows InterMed Discovery to develop innovative and proprietary active ingredients for specific applications to market-readiness. InterMed Discovery is thus increasing its added value while extending its market access.
“The combination of InterMed Discovery’s natural product data and active ingredients with Cognis’ know-how and market expertise in nutrition and cosmetics creates a unique platform for the development of new, innovative products and thus strengthens our market position sustainably,” said Norbert Weitkemper, director strategic business development nutrition and health, Cognis.
In addition to its own development projects for defined applications InterMed Discovery enters into strategic partnerships. “This cooperation with Cognis is therefore an important milestone in positioning us as a leading company in the discovery and development of active compounds based on natural products,” said Bernard Becker and Thomas Henkel, managers of InterMed Discovery.